| Revisiting biomarker discovery by plasma proteomics PE Geyer, LM Holdt, D Teupser, M Mann Molecular systems biology 13 (9), 942, 2017 | 1005 | 2017 |
| Plasma proteome profiling to assess human health and disease PE Geyer, NA Kulak, G Pichler, LM Holdt, D Teupser, M Mann Cell systems 2 (3), 185-195, 2016 | 806 | 2016 |
| A novel LC system embeds analytes in pre-formed gradients for rapid, ultra-robust proteomics N Bache, PE Geyer, DB Bekker-Jensen, O Hoerning, L Falkenby, PV Treit, ... Molecular & Cellular Proteomics 17 (11), 2284-2296, 2018 | 440 | 2018 |
| Profiling the human intestinal environment under physiological conditions D Shalon, RN Culver, JA Grembi, J Folz, PV Treit, H Shi, FA Rosenberger, ... Nature 617 (7961), 581-591, 2023 | 423 | 2023 |
| A knowledge graph to interpret clinical proteomics data A Santos, AR Colaço, AB Nielsen, L Niu, M Strauss, PE Geyer, F Coscia, ... Nature biotechnology 40 (5), 692-702, 2022 | 359* | 2022 |
| BoxCar acquisition method enables single-shot proteomics at a depth of 10,000 proteins in 100 minutes F Meier, PE Geyer, S Virreira Winter, J Cox, M Mann Nature methods 15 (6), 440-448, 2018 | 359 | 2018 |
| Region and cell-type resolved quantitative proteomic map of the human heart S Doll, M Dreßen, PE Geyer, DN Itzhak, C Braun, SA Doppler, F Meier, ... Nature communications 8 (1), 1469, 2017 | 324 | 2017 |
| Plasma proteome profiling to detect and avoid sample‐related biases in biomarker studies PE Geyer, E Voytik, PV Treit, S Doll, A Kleinhempel, L Niu, JB Müller, ... EMBO molecular medicine 11 (11), EMMM201910427, 2019 | 319 | 2019 |
| Plasma proteome profiling discovers novel proteins associated with non‐alcoholic fatty liver disease L Niu, PE Geyer, NJ Wewer Albrechtsen, LL Gluud, A Santos, S Doll, ... Molecular systems biology 15 (3), e8793, 2019 | 302 | 2019 |
| Proteome profiling in cerebrospinal fluid reveals novel biomarkers of Alzheimer's disease JM Bader, PE Geyer, JB Müller, MT Strauss, M Koch, F Leypoldt, ... Molecular systems biology 16 (6), e9356, 2020 | 290 | 2020 |
| Noninvasive proteomic biomarkers for alcohol-related liver disease L Niu, M Thiele, PE Geyer, DN Rasmussen, HE Webel, A Santos, R Gupta, ... Nature Medicine 28 (6), 1277-1287, 2022 | 280 | 2022 |
| Ultra-deep and quantitative saliva proteome reveals dynamics of the oral microbiome N Grassl, NA Kulak, G Pichler, PE Geyer, J Jung, S Schubert, P Sinitcyn, ... Genome medicine 8 (1), 44, 2016 | 266 | 2016 |
| Proteomics reveals the effects of sustained weight loss on the human plasma proteome PE Geyer, NJ Wewer Albrechtsen, S Tyanova, N Grassl, EW Iepsen, ... Molecular systems biology 12 (12), 901, 2016 | 259 | 2016 |
| Advances and utility of the human plasma proteome EW Deutsch, GS Omenn, Z Sun, M Maes, M Pernemalm, KK Palaniappan, ... Journal of proteome research 20 (12), 5241-5263, 2021 | 248 | 2021 |
| Mass spectrometry-based plasma proteomics: considerations from sample collection to achieving translational data V Ignjatovic, PE Geyer, KK Palaniappan, JE Chaaban, GS Omenn, ... Journal of proteome research 18 (12), 4085-4097, 2019 | 245 | 2019 |
| Loss-less nano-fractionator for high sensitivity, high coverage proteomics NA Kulak, PE Geyer, M Mann Molecular & Cellular Proteomics 16 (4), 694-705, 2017 | 221 | 2017 |
| The proteome landscape of the kingdoms of life JB Müller, PE Geyer, AR Colaço, PV Treit, MT Strauss, M Oroshi, S Doll, ... Nature 582 (7813), 592-596, 2020 | 204 | 2020 |
| High‐resolution serum proteome trajectories in COVID‐19 reveal patient‐specific seroconversion PE Geyer, FM Arend, S Doll, ML Louiset, S Virreira Winter, JB Müller‐Reif, ... EMBO Molecular Medicine 13 (8), e14167, 2021 | 133 | 2021 |
| Proteomics for blood biomarker exploration of severe mental illness: pitfalls of the past and potential for the future AL Comes, S Papiol, T Mueller, PE Geyer, M Mann, TG Schulze Translational psychiatry 8 (1), 160, 2018 | 116 | 2018 |
| Mechanisms preserving insulin action during high dietary fat intake AM Lundsgaard, JB Holm, KA Sjøberg, KN Bojsen-Møller, LS Myrmel, ... Cell Metabolism 29 (1), 50-63. e4, 2019 | 113 | 2019 |
Matthias MannMax Planck Institute of Biochemistry, Munich and CPR, University of CopenhagenVerified email at biochem.mpg.de
